We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




New Review Throws Doubt on Wound Care Treatments

By HospiMedica International staff writers
Posted on 15 Jan 2014
A new systematic review of the treatment of skin ulcers suggests that most studies are so technically flawed that their results cannot be trusted.

Researchers at Johns Hopkins University (JHU; Baltimore, MD, USA) conducted a systematic review of studies examining the comparative effectiveness of advanced wound dressings, antibiotics, and surgical management of chronic venous ulcers. More...
The researchers found that of 10,066 citations identified in the literature search, only 66 (0.06%) met liberal inclusion criteria for providing evidence on the effectiveness of interventions for chronic venous ulcers, while the vast majority of the studies suffered from important research gaps and methodological deficiencies.

From the studies that did meet the criteria, the researchers found that dressings that used living human cells increased wound healing. Another finding was that cadexomer iodine and collagen may also increase healing. The evidence was inconclusive regarding the use of systemic antibiotics, unless demonstrated signs of infection were found. Surgical treatments such as radiofrequency ablation, endovenous laser treatment, and sclerotherapy helped healing, while surgical correction of the underlying pathology did help to decrease recurrence of ulcers. The review was published online ahead of print on October 17, 2013, in Wound Repair and Regeneration.

“There is a critical need for well-designed research studies to compare the current minimally invasive surgical interventions to the gold standard of care, compression therapy,” concluded lead author Gerald Lazarus, MD, and colleagues of the JHU Evidence-Based Practice Center. “The review should serve as a means to bring the wound healing community together to improve the situation.”

Compression therapy is the recognized treatment of choice for recurrent venous leg ulcers, combining two mechanisms of action: a static effect (resting pressure) and a dynamic effect due to the changing circumference of the leg during walking. Effective compression is achieved by accurate application of hosiery, tubular bandages, and bandage systems, which provide some compression at rest, but work effectively during exercise. These systems are intended to provide graduated compression to the lower limb in order to improve venous return and lymphatic drainage, thus also reducing edema.

Related Links:

Johns Hopkins University



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Electric Bed
DIXION Intensive Care Bed
Emergency Ventilator
Shangrila935
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.